synthesis of 5,6-dihydro-3-(4-morpholino-1-piperidinyl)phenyl]-2(1h)-pyridone_kain industrial additive
background and overview[1] 5,6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidyl)phenyl]-2(1h)-pyridone is a one of the impurities in pixaban. apixaban is an oral, selective activated factor x inhibitor jointly developed by pfizer and bristol-myers squibb. in january 2013, it obtained the import drug license issued by the state food and drug administration of china and was officially launched in china in april…

